VERU INC. Other Noncash Income (Expense)
VERU INC. (VERU) reported Other Noncash Income (Expense) of $69.30 thousand for the 9-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2024-08-08
- VERU INC. other noncash income (expense) for the quarter ending 2024-06-30 was $79.43K.
- VERU INC. other noncash income (expense) for the quarter ending 2024-03-31 was -$38.27K.
- VERU INC. other noncash income (expense) for the quarter ending 2023-12-31 was $28.15K.
- VERU INC. other noncash income (expense) for the quarter ending 2023-09-30 was -$40.13K.
- VERU INC. other noncash income (expense) for fiscal 2023 was -$1.87M.
- VERU INC. other noncash income (expense) for fiscal 2022 was -$1.75M, a 148.64% decline from fiscal 2021.
- VERU INC. other noncash income (expense) for fiscal 2021 was $3.59M.
- VERU INC. other noncash income (expense) for fiscal 2020 was -$4.31M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | $79.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | $41.16K derived: sum of 2 quarters · filed 2024-08-08 | $69.30K 10-Q · filed 2024-08-08 | $29.17K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2024-03-31 | -$38.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | -$10.13K 10-Q · filed 2024-05-08 | -$50.26K derived: sum of 3 quarters · filed 2024-05-08 | -$565.74K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-12-31 | $28.15K 10-Q · filed 2024-04-01 | -$11.98K derived: sum of 2 quarters · filed 2024-04-01 | -$527.46K derived: sum of 3 quarters · filed 2024-08-08 | -$1.10M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-09-30 | -$40.13K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-01 | -$555.61K derived: sum of 2 quarters · filed 2024-08-08 | -$1.13M derived: sum of 3 quarters · filed 2024-08-08 | -$1.87M 10-K/A · filed 2024-04-01 | |
| 2023-06-30 | -$515.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | -$1.09M derived: sum of 2 quarters · filed 2024-08-08 | -$1.83M 10-Q · filed 2024-08-08 | -$2.16M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$572.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | -$1.32M 10-Q · filed 2024-05-08 | -$1.65M derived: sum of 3 quarters · filed 2024-05-08 | -$2.18M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | -$743.92K 10-Q · filed 2024-04-01 | -$1.08M derived: sum of 2 quarters · filed 2024-04-01 | -$1.61M derived: sum of 3 quarters · filed 2024-04-01 | -$2.12M derived: sum of 4 quarters · filed 2024-04-01 | |
| 2022-09-30 | -$332.21K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | -$865.88K derived: sum of 2 quarters · filed 2024-04-01 | -$1.37M derived: sum of 3 quarters · filed 2024-04-01 | -$1.75M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | -$533.67K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-11-15 | -$1.04M derived: sum of 2 quarters · filed 2023-11-15 | -$1.42M 10-Q/A · filed 2023-11-15 | -$745.39K derived: sum of 4 quarters · filed 2023-11-15 | |
| 2022-03-31 | -$505.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$882.30K 10-Q · filed 2023-05-11 | -$211.72K derived: sum of 3 quarters · filed 2023-05-11 | $2.68M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$376.36K 10-Q · filed 2023-02-09 | $294.23K derived: sum of 2 quarters · filed 2023-02-09 | $3.19M derived: sum of 3 quarters · filed 2023-02-09 | $3.31M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-09-30 | $670.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $3.56M derived: sum of 2 quarters · filed 2022-12-05 | $3.69M derived: sum of 3 quarters · filed 2022-12-05 | $3.59M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $3.02M derived: sum of 2 quarters · filed 2022-08-11 | $2.92M 10-Q · filed 2022-08-11 | $2.09M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $123.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $31.07K 10-Q · filed 2022-05-12 | -$799.78K derived: sum of 3 quarters · filed 2022-05-12 | -$1.97M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$92.79K 10-Q · filed 2022-02-09 | -$923.64K derived: sum of 2 quarters · filed 2022-02-09 | -$2.09M derived: sum of 3 quarters · filed 2022-02-09 | -$3.26M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$830.85K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | -$2.00M derived: sum of 2 quarters · filed 2021-12-02 | -$3.17M derived: sum of 3 quarters · filed 2021-12-02 | -$4.31M 10-K · filed 2021-12-02 | |
| 2020-06-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | -$2.33M derived: sum of 2 quarters · filed 2021-08-12 | -$3.48M 10-Q · filed 2021-08-12 | -$4.55M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-12 | -$2.31M 10-Q · filed 2021-05-12 | -$3.38M derived: sum of 3 quarters · filed 2021-05-12 | -$4.48M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$1.14M 10-Q · filed 2021-02-10 | -$2.22M derived: sum of 2 quarters · filed 2021-02-10 | -$3.31M derived: sum of 3 quarters · filed 2021-02-10 | -$4.57M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-09-30 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$2.17M derived: sum of 2 quarters · filed 2020-12-10 | -$3.43M derived: sum of 3 quarters · filed 2020-12-10 | -$4.71M 10-K · filed 2020-12-10 | |
| 2019-06-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | -$2.35M derived: sum of 2 quarters · filed 2020-08-13 | -$3.63M 10-Q · filed 2020-08-13 | -$4.85M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | -$2.54M 10-Q · filed 2020-05-13 | -$3.76M derived: sum of 3 quarters · filed 2020-05-13 | -$5.14M derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | -$1.28M 10-Q · filed 2020-02-12 | -$2.50M derived: sum of 2 quarters · filed 2020-02-12 | -$3.88M derived: sum of 3 quarters · filed 2020-02-12 | ||
| 2018-09-30 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | -$2.60M derived: sum of 2 quarters · filed 2019-12-12 | -$2.95M 10-K · filed 2019-12-12 | ||
| 2018-06-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | -$1.73M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | -$350.60K 10-Q · filed 2019-05-15 | $350.60K 10-Q · filed 2018-05-11 | |||
| 2009-09-30 | -$418.81K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |